Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Ferri

Showing results (41-50 of 343) with videos related to

Pageof 35
Sort By:
Journal of the American Society of Hypertension : JASH|May 28, 2018
Diastolic blood pressure and risk profile in renal and cardiovascular diseases. Results from the SPRINT trialRita Del Pinto, Davide Pietropaoli, Claudio Ferri
International Journal of Molecular Sciences|November 8, 2017
Vitamin D Axis in Inflammatory Bowel Diseases: Role, Current Uses and Future PerspectivesRita Del Pinto, Claudio Ferri, Fabio Cominelli
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 15, 2018
Considerations on stroke in atrial fibrillation despite anticoagulationPaolo Di Giosia, Paolo Giorgini, Claudio Ferri
Circulation|June 13, 2018
Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"Rita Del Pinto, Claudio Ferri, Claudio Borghi
Journal of Hypertension|February 7, 2020
Reduction of blood pressure variability: an additional protective cardiovascular effect of vasodilating beta-blockers?Rita Del Pinto, Claudio Ferri, Gianfranco Parati
Journal of Cardiology|August 2, 2020
COVID-19 and cardiovascular diseasesFrancesca Mai, Rita Del Pinto, Claudio Ferri
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 12, 2016
Is labor-onset hypertension a novel category among hypertensive disorders of pregnancy associated with adverse events in high-risk subjects? Lights and shadowsPaolo Di Giosia, Paolo Giorgini, Claudio Ferri
Expert Review of Cardiovascular Therapy|November 21, 2008
Electrophysiological effects of short-term antihypertensive therapyClaudio Ferri, Paolo Pasqualetti, Sergio Tiberti, et al.
Current Pharmaceutical Design|June 23, 2007
COX-2: friend or foe?Annalisa Iezzi, Claudio Ferri, Andrea Mezzetti, et al.
Current Pharmaceutical Design|August 5, 2008
Morphology of atherosclerotic plaque: its feature by imaging studyGabriella Passacquale, Sergio Tiberti, Claudio Ferri, et al.
Pageof 35

Showing results (41-50 of 343) with videos related to

Sort By:
Pageof 35
Journal of the American Society of Hypertension : JASH|May 28, 2018
Diastolic blood pressure and risk profile in renal and cardiovascular diseases. Results from the SPRINT trialRita Del Pinto, Davide Pietropaoli, Claudio Ferri
International Journal of Molecular Sciences|November 8, 2017
Vitamin D Axis in Inflammatory Bowel Diseases: Role, Current Uses and Future PerspectivesRita Del Pinto, Claudio Ferri, Fabio Cominelli
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 15, 2018
Considerations on stroke in atrial fibrillation despite anticoagulationPaolo Di Giosia, Paolo Giorgini, Claudio Ferri
Circulation|June 13, 2018
Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"Rita Del Pinto, Claudio Ferri, Claudio Borghi
Journal of Hypertension|February 7, 2020
Reduction of blood pressure variability: an additional protective cardiovascular effect of vasodilating beta-blockers?Rita Del Pinto, Claudio Ferri, Gianfranco Parati
Journal of Cardiology|August 2, 2020
COVID-19 and cardiovascular diseasesFrancesca Mai, Rita Del Pinto, Claudio Ferri
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 12, 2016
Is labor-onset hypertension a novel category among hypertensive disorders of pregnancy associated with adverse events in high-risk subjects? Lights and shadowsPaolo Di Giosia, Paolo Giorgini, Claudio Ferri
Expert Review of Cardiovascular Therapy|November 21, 2008
Electrophysiological effects of short-term antihypertensive therapyClaudio Ferri, Paolo Pasqualetti, Sergio Tiberti, et al.
Current Pharmaceutical Design|June 23, 2007
COX-2: friend or foe?Annalisa Iezzi, Claudio Ferri, Andrea Mezzetti, et al.
Current Pharmaceutical Design|August 5, 2008
Morphology of atherosclerotic plaque: its feature by imaging studyGabriella Passacquale, Sergio Tiberti, Claudio Ferri, et al.
Pageof 35